Research

Impact of coronavirus pandemic on our research programme

During the ongoing coronavirus pandemic work on our research projects is either delayed or suspended. Many of the researchers are supporting the response to the pandemic by either returning to clinical work or assisting with the increased need for COVID-19 testing and vaccine deployment. We remain in contact with all research teams and will provide updates on the progress of individual projects as soon as we can.

Meningitis Now is working towards a future where no-one in the UK loses their life to meningitis and everyone affected gets the support they need to rebuild their lives.

Our founder Steve Dayman started the meningitis movement in the early 1980s after his son, Spencer, died from meningococcal disease. Since then, we have funded more than £12 million of vital research through the Spencer Dayman Research Fund.

In recent decades there have been many important advances in the prevention and treatment of meningitis, and this has been accompanied by a decline in the number of cases, particularly in recent years. Despite this, new cases of disease are still causing death and disability each year, and many others continue to live with the life-long impact. Our continued investment in research is vital.